Biotest
BIO.F
$43.84
Share price
0.00%
Change (1 day)
-7.41%
Change (1 year)
Categories
Biotest (BIO.F) - Cash on Hand
Cash on Hand as of December 2023 : $0.13 B
According to Biotest
's latest financial reports the company has $0.13 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Biotest - Cash on Hand chart (from 2009 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $0.14 B | 9.94% |
| 2021-12-31 | $0.13 B | 21.29% |
| 2020-12-31 | $0.10 B | 14.28% |
| 2019-12-31 | $96 M | -20.91% |
| 2018-12-31 | $0.12 B | 258.53% |
| 2017-12-31 | $33.85 M | -61.21% |
| 2016-12-31 | $87.26 M | -48.07% |
| 2015-12-31 | $0.16 B | -40.97% |
| 2014-12-31 | $0.28 B | 0.86% |
| 2013-12-31 | $0.28 B | 273.08% |
| 2012-12-31 | $75.66 M | -29.83% |
| 2011-12-31 | $0.10 B | 337.22% |
| 2010-12-31 | $24.66 M | 155.77% |
| 2009-12-31 | $9.64 M | -14.56% |
| 2008-12-31 | $11.28 M | -13.05% |
| 2007-12-31 | $12.97 M | 10.28% |
| 2006-12-31 | $11.76 M | 31.23% |
| 2005-12-31 | $8.96 M | -66.34% |
| 2004-12-31 | $26.64 M | 74.63% |
| 2003-12-31 | $15.25 M | 76.45% |
| 2002-12-31 | $8.64 M |